Welcome to
Austin Heart
Austin Heart’s Research Division contributes daily to the advancement of the science of cardiovascular medicine guided by an unwavering commitment to integrity and driven by a passion to provide the best possible care for all of our patients.
Research Mission Statement:
Austin Heart’s clinical research program is dedicated to providing the most innovative and progressive care to our patients, while advancing the science of medicine through the conduct of clinical trials.
Research Highlights:
- Austin Heart boasts one of the largest clinical cardiology research programs in the world with more than 20 years of national and international research experience.
- Austin Heart physicians are currently involved in over 50 trials ranging from local investigator-initiated pilot studies to landmark multi-center international trials.
- Our research encompasses all disciplines of cardiology, including:
- Peripheral and coronary angiogenesis, including research involving gene transfer, growth factors and stem cell therapy;
- Stem cell therapy for limb salvage in patients with peripheral arterial occlusive disease and myocardial repair in patients with recent myocardial infarction;
- Austin Heart was chosen as one of only 10 sites in the United States for Phase 1 stem cell research for patients with myocardial infarction
- Austin Heart was the first among all centers worldwide to enroll a Phase 2 study patient
- Austin Heart has treated more patients in this multinational stem cell trial than any other research center
- Major contributions to the validation of the use of stents versus traditional endarterectomy surgery for the treatment of carotid artery stenosis;
- Austin Heart supports one of the leading electrophysiology research centers for devices used arrhythmia mapping and management, ablation catheters, NOGA electromechanical viability mapping, and robotic guidance and steering systems;
- Advancing diagnostic testing capability through advanced lab testing, genetic studies;
- Nuclear/PET testing, intra-vascular ultrasound (IVUS), and optical coherence tomography (OCT);
- Testing new medications for hyperlipidemia, atherosclerosis, congestive heart failure, anti-coagulation, and anti-platelet therapy.
Contact Information:
Department Manager:
Polly Mock RN, CCRC
Polly.Mock@HCAhealthcare.com
Phone 512-421-3851
Fax 512-421-3827
Medical Director:
Roger Gammon M.D.
Roger.Gammon@HCAhealthcare.com
Phone 512-206-3600
Research Locations:
Research Experience:
Austin Heart Research Curriculum Vitae
